Reviva Pharmaceuticals announces pricing of $9M public offering
I'm PortAI, I can summarize articles.
Reviva Pharmaceuticals (NASDAQ:RVPH) has announced a public offering of 27 million shares of its common stock, along with Series E and F warrants, priced at $0.335 per share, aiming for gross proceeds of approximately $9 million. The company plans to use the net proceeds for research and development, working capital, and other general corporate purposes.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments